OPKO Health Executive and Leadership Team

Phil Frost, the Chief Executive Officer & Chairman at OPKO Health, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the integration of pharmaceutical development and diagnostic services, the Chief Executive Officer & Chairman ensures alignment between research initiatives and commercial objectives. This leadership role involves guiding the board through complex regulatory landscapes while fostering innovation across the company's diverse therapeutic portfolio. By prioritizing the expansion of multispecific antibody therapies and clinical testing capabilities, Frost drives the company toward sustainable growth in the global healthcare market. The Chief Executive Officer & Chairman maintains rigorous oversight of capital allocation to support the discovery of new medicines for serious diseases. Through consistent focus on operational excellence, Phil Frost secures the company's position as a leader in the healthcare sector, ensuring that all business units contribute effectively to the broader mission of improving patient outcomes.

Charles Bishop, the Chief Executive Officer, OPKO Renal at OPKO Health, manages the specialized development and commercialization of treatments within the endocrinology and renal therapeutic areas. Overseeing clinical trials and regulatory submissions, the Chief Executive Officer, OPKO Renal ensures that innovative therapies reach patients suffering from chronic kidney conditions. This leadership role involves coordinating with research teams to advance the pipeline of pharmaceutical products while maintaining strict compliance with international health standards. By optimizing the go-to-market strategy for renal-specific medicines, Bishop drives revenue growth and strengthens the company's footprint in the endocrinology space. The Chief Executive Officer, OPKO Renal collaborates with cross-functional departments to translate scientific discoveries into viable commercial solutions. Through strategic management of the renal portfolio, Charles Bishop enhances the company's reputation for delivering high-impact medical interventions that address significant unmet needs in the global healthcare landscape.

Adam Logal, the Chief Financial Officer & Senior VP at OPKO Health, manages the financial health, reporting, and fiscal planning for the entire organization. Overseeing the company's capital structure and investment strategies, the Chief Financial Officer & Senior VP ensures that resources support the ongoing development of pharmaceutical platforms and diagnostic infrastructure. This leadership role involves maintaining transparency with shareholders and the investment community while navigating the complexities of a publicly traded entity on the NASDAQ. By optimizing operational budgets and monitoring financial performance across international subsidiaries, Logal drives efficiency and long-term stability. The Chief Financial Officer & Senior VP collaborates with executive leadership to evaluate potential acquisitions and strategic partnerships that align with the company's growth trajectory. Through meticulous financial oversight, Adam Logal secures the necessary funding to sustain the company's research and development efforts, ultimately supporting the delivery of advanced healthcare solutions to patients worldwide.

Adam Ali, the Chief Marketing Officer & Team Leader (US) at OPKO Health, architects the commercial outreach and brand positioning strategies across the United States market. Overseeing the promotion of diagnostic testing services and pharmaceutical products, the Chief Marketing Officer & Team Leader (US) ensures that healthcare providers understand the value of the company's molecular diagnostics and genetic testing capabilities. This leadership role involves analyzing market trends to identify growth opportunities within the competitive landscape of clinical reference laboratories. By aligning marketing campaigns with the specific needs of women's health and anatomical pathology sectors, Ali drives increased utilization of diagnostic services. The Chief Marketing Officer & Team Leader (US) coordinates with sales teams to maximize market penetration and brand awareness. Through data-driven decision-making, Adam Ali strengthens the company's presence in the domestic healthcare market, ensuring that diagnostic solutions remain at the forefront of clinical practice and patient care.

Jane Hsiao, the Chief Technical Officer & Vice Chairman at OPKO Health, directs the scientific innovation and technical development of the company's pharmaceutical and diagnostic technologies. Overseeing the laboratory operations and the advancement of multispecific antibody therapies, the Chief Technical Officer & Vice Chairman ensures that the company maintains a competitive edge in biotechnology and molecular diagnostics. This leadership role involves guiding research teams through the discovery phase of new medicines for oncology and infectious diseases. By fostering a culture of technical excellence, Hsiao drives the development of proprietary testing services that enhance the company's diagnostic portfolio. The Chief Technical Officer & Vice Chairman collaborates with the board to evaluate emerging technologies and scientific breakthroughs that align with the company's long-term mission. Through rigorous technical oversight, Jane Hsiao ensures that all products meet the highest standards of quality and efficacy, solidifying the company's status as a pioneer in integrated healthcare innovation.